Related Experiment Video
Updated: Apr 29, 2026
12:34
DNA Methylation: Bisulphite Modification and Analysis
Published on: October 21, 2011
108.9K
Detection of DNA methylation changes in body fluids
Triantafillos Liloglou1, John K Field
1University of Liverpool Cancer Research Centre, Liverpool, United Kingdom.
Advances in Genetics
|October 12, 2010
Summary
DNA methylation changes in body fluids show promise as biomarkers for diagnosing diseases, including cancer. Further research is needed to overcome challenges in clinical implementation.
Area of Science:
- Biochemistry
- Molecular Biology
- Genetics
Background:
- Epigenetic reprogramming, particularly DNA methylation deregulation, is implicated in numerous human diseases.
- DNA methylation offers unique biomarker potential due to its chemical properties and technological advancements.
Purpose of the Study:
- To summarize evidence on DNA methylation in human body fluids for disease diagnostics.
- To demonstrate the clinical potential of DNA methylation in cancer diagnostics.
- To discuss technical approaches, quality control, and implementation challenges.
Main Methods:
- Review of existing studies on DNA methylation in body fluids.
- Analysis of technical approaches for DNA methylation detection.
- Evaluation of biomarker validation and clinical implementation strategies.
Main Results:
- DNA methylation alterations are detectable in various body fluids.
- Significant evidence supports the role of DNA methylation in diagnosing malignant and benign diseases.
- Technical challenges and quality control issues impact reliability.
Conclusions:
- DNA methylation holds considerable clinical potential for cancer diagnostics and disease detection.
- Standardization of technical approaches and rigorous study design are crucial for clinical translation.
- Addressing pitfalls in biomarker validation is essential for successful implementation.
